Evolocumab

Records for this ingredient, by country (identity only).

ATC C10AX13 · 12 markets · 26 records

Evolocumab 12 markets · 26 records Forms
Filters

US 5 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 140 mg per mL / per unit basis not statedinjectionREPATHA

AU 4 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 140 mg/1 mLinjectionREPATHA also in ES·GB·JP
    +1Other 1 marketsFR
  • 140 mg per mL / per unit basis not statedinjectionREPATHA evolocumab (rch) 140 mg/mL injection solution syringeREPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 3 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

GB 2 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 140 mg/1 mLinjectionRepatha 140mg/1ml solution for injection pre-filled syringesRepatha SureClick 140mg/1ml solution for injection pre-filled pens also in AU·ES·JP
    +1Other 1 marketsFR

SG 2 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

TW 2 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名"Amgen" Repatha Solution for Injection ×1"安進"瑞百安注射液 ×1Repatha Solution for Injection ×1瑞百安注射液 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名REPATHA SOLUTION FOR INJECTION IN PRE-FILLED AUTOINJECTOR 140MG/ML ×1REPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 140 mg per mL / per unit basis not statedliquidREPATHA

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 140 mg/1 mLinjectionレパーサ皮下注140mgペン also in AU·ES·GB
    +1Other 1 marketsFR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 140 mg/1 mLinjectionREPATHA 140 mg, solution injectable en stylo prérempli also in AU·ES·GB
    +1Other 1 marketsJP

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.